Page 40 - Devika Syamnath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday. "If GLP-1 usage ultimately increases by this amount and results in lower obesity rates, we see scope for significant spillovers to the broader economy," Goldman economists said

(Reuters) - The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost workplace efficiency, according to Goldman...

U.S. smartphone sales plunged 10% in January on weak demand for cheaper Android devices and as customers delayed upgrades ahead of the launch of Samsung Electronics' Galaxy S24 series, according to...

(Reuters) - Palo Alto Networks sank 23% on Wednesday and sparked a selloff in cybersecurity stocks after softer client spending and steep promotions forced the company to cut its annual billings forecast. The industry heavyweight will lose around $...

Palo Alto Networks sank 23% on Wednesday and sparked a selloff in cybersecurity stocks after softer client spending and steep promotions forced the company to cut its annual billings forecast. ...